Treatment with Huperzine A Improves Cognition in Vascular Dementia Patients
β Scribed by Zhi-Qiang Xu; Xiao-Min Liang; Juan-Wu; Yuan-Feng Zhang; Chun-Xia Zhu; Xiao-Jiang Jiang
- Book ID
- 107567865
- Publisher
- Springer-Verlag
- Year
- 2011
- Tongue
- English
- Weight
- 156 KB
- Volume
- 62
- Category
- Article
- ISSN
- 1085-9195
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Objective To screen for cognitive assessment for patients with vascular cognitive impairment (VCI) no dementia (VβCIND) from a set of cognitive measures. ## Methods Extensive neuropsychological tests covering five cognitive domains were performed on 80 VβCIND patients and 80 norma
Patients suffering from dementia exhibit depressive symptoms in up to 86 per cent of cases. Syndromes meeting the criteria for major depression are more likely to respond to pharmacological therapy. Increased activity of M A 0 found in demented subjects make the treatment with MAO-inhibitors an obvi
## Abstract ## Background Vascular dementia (VaD) is associated with impairments in cognitive, motor, and functional domains. Patients with VaD display diverse cognitive and motor deficits, however, and relationships between these impairments and independent living abilities remain unclear. ## Ob
## Abstract Chronic cerebral hypoperfusion has been suggested to contribute to the progression of dementia. Inflammation and white matter lesion (WML) are involved in the pathologic process. This study investigated whether huperzine A, a natural acetylcholinesterase (AChE) inhibitor, has beneficial